Wei Lin - 13 Jun 2023 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)

Role
Director
Signature
/s/ Teresa Jurgensen, Attorney-in-Fact
Issuer symbol
TSVT
Transactions as of
13 Jun 2023
Transactions value $
$0
Form type
4
Filing time
15 Jun 2023, 17:00:44 UTC
Previous filing
09 Mar 2023
Next filing
29 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSVT Common Stock Award $0 +4.2K +25.3% $0.00 20.8K 13 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSVT Stock Option (right to buy) Award $0 +8.45K $0.00 8.45K 13 Jun 2023 Common Stock 8.45K $11.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units vest 100% on the earlier of June 13, 2024 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.
F2 This option vests 100% on the earlier of June 13, 2024 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.

Remarks:

Exhibit List: Exhibit 24. This Power of Attorney was inadvertently omitted from the Form 3 filed on March 9, 2023.